Global Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Overview:
Global Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Adeno-associated Virus (AAV) Vector-based Gene Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Adeno-associated Virus (AAV) Vector-based Gene Therapy Market:
The Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Adeno-associated Virus (AAV) Vector-based Gene Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Adeno-associated Virus (AAV) Vector-based Gene Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Adeno-associated Virus (AAV) Vector-based Gene Therapy market has been segmented into:
Internal Loop Airlift Bioreactor
External Loop Airlift Bioreactor
Sparged Airlift Bioreactor
By Application, Adeno-associated Virus (AAV) Vector-based Gene Therapy market has been segmented into:
Hematological Malignancies
Neurological Disorders
Cardiovascular Diseases
Ophthalmic Diseases
Oncology
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Adeno-associated Virus (AAV) Vector-based Gene Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Adeno-associated Virus (AAV) Vector-based Gene Therapy market.
Top Key Players Covered in Adeno-associated Virus (AAV) Vector-based Gene Therapy market are:
uniQure
Lysogene
AveXis
Sangamo Therapeutics
Dimension Therapeutics
Regenxbio
Bluebird Bio
Audentes Therapeutics
Spark Therapeutics
Oxford BioMedica
Urogen Pharma
Solid Biosciences
ReNeuron
Voyager Therapeutics
Nightstar Therapeutics
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Type
4.1 Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Snapshot and Growth Engine
4.2 Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Overview
4.3 Internal Loop Airlift Bioreactor
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Internal Loop Airlift Bioreactor: Geographic Segmentation Analysis
4.4 External Loop Airlift Bioreactor
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 External Loop Airlift Bioreactor: Geographic Segmentation Analysis
4.5 Sparged Airlift Bioreactor
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Sparged Airlift Bioreactor: Geographic Segmentation Analysis
Chapter 5: Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Application
5.1 Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Snapshot and Growth Engine
5.2 Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Overview
5.3 Hematological Malignancies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Hematological Malignancies: Geographic Segmentation Analysis
5.4 Neurological Disorders
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Neurological Disorders: Geographic Segmentation Analysis
5.5 Cardiovascular Diseases
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Cardiovascular Diseases: Geographic Segmentation Analysis
5.6 Ophthalmic Diseases
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Ophthalmic Diseases: Geographic Segmentation Analysis
5.7 Oncology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Oncology: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 UNIQURE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 LYSOGENE
6.4 AVEXIS
6.5 SANGAMO THERAPEUTICS
6.6 DIMENSION THERAPEUTICS
6.7 REGENXBIO
6.8 BLUEBIRD BIO
6.9 AUDENTES THERAPEUTICS
6.10 SPARK THERAPEUTICS
6.11 OXFORD BIOMEDICA
6.12 UROGEN PHARMA
6.13 SOLID BIOSCIENCES
6.14 RENEURON
6.15 VOYAGER THERAPEUTICS
6.16 NIGHTSTAR THERAPEUTICS
Chapter 7: Global Adeno-associated Virus (AAV) Vector-based Gene Therapy Market By Region
7.1 Overview
7.2. North America Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Internal Loop Airlift Bioreactor
7.2.2.2 External Loop Airlift Bioreactor
7.2.2.3 Sparged Airlift Bioreactor
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Hematological Malignancies
7.2.3.2 Neurological Disorders
7.2.3.3 Cardiovascular Diseases
7.2.3.4 Ophthalmic Diseases
7.2.3.5 Oncology
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Internal Loop Airlift Bioreactor
7.3.2.2 External Loop Airlift Bioreactor
7.3.2.3 Sparged Airlift Bioreactor
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Hematological Malignancies
7.3.3.2 Neurological Disorders
7.3.3.3 Cardiovascular Diseases
7.3.3.4 Ophthalmic Diseases
7.3.3.5 Oncology
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Internal Loop Airlift Bioreactor
7.4.2.2 External Loop Airlift Bioreactor
7.4.2.3 Sparged Airlift Bioreactor
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Hematological Malignancies
7.4.3.2 Neurological Disorders
7.4.3.3 Cardiovascular Diseases
7.4.3.4 Ophthalmic Diseases
7.4.3.5 Oncology
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Internal Loop Airlift Bioreactor
7.5.2.2 External Loop Airlift Bioreactor
7.5.2.3 Sparged Airlift Bioreactor
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Hematological Malignancies
7.5.3.2 Neurological Disorders
7.5.3.3 Cardiovascular Diseases
7.5.3.4 Ophthalmic Diseases
7.5.3.5 Oncology
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Internal Loop Airlift Bioreactor
7.6.2.2 External Loop Airlift Bioreactor
7.6.2.3 Sparged Airlift Bioreactor
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Hematological Malignancies
7.6.3.2 Neurological Disorders
7.6.3.3 Cardiovascular Diseases
7.6.3.4 Ophthalmic Diseases
7.6.3.5 Oncology
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Internal Loop Airlift Bioreactor
7.7.2.2 External Loop Airlift Bioreactor
7.7.2.3 Sparged Airlift Bioreactor
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Hematological Malignancies
7.7.3.2 Neurological Disorders
7.7.3.3 Cardiovascular Diseases
7.7.3.4 Ophthalmic Diseases
7.7.3.5 Oncology
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Adeno-associated Virus (AAV) Vector-based Gene Therapy Scope:
|
Report Data
|
Adeno-associated Virus (AAV) Vector-based Gene Therapy Market
|
|
Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Size in 2025
|
USD XX million
|
|
Adeno-associated Virus (AAV) Vector-based Gene Therapy CAGR 2025 - 2032
|
XX%
|
|
Adeno-associated Virus (AAV) Vector-based Gene Therapy Base Year
|
2024
|
|
Adeno-associated Virus (AAV) Vector-based Gene Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
uniQure, Lysogene, AveXis, Sangamo Therapeutics, Dimension Therapeutics, Regenxbio, Bluebird Bio, Audentes Therapeutics, Spark Therapeutics, Oxford BioMedica, Urogen Pharma, Solid Biosciences, ReNeuron, Voyager Therapeutics, Nightstar Therapeutics.
|
|
Key Segments
|
By Type
Internal Loop Airlift Bioreactor
External Loop Airlift Bioreactor
Sparged Airlift Bioreactor
By Applications
Hematological Malignancies
Neurological Disorders
Cardiovascular Diseases
Ophthalmic Diseases
Oncology
|
